Healthcare -
Biotechnology - NASDAQ - US
$ 3.94
2.07 %
$ 278 M
Market Cap
-2.42
P/E
CCCC - LONG-TERM DEBT
Long-term Debt CCCC - C4 Therapeutics, Inc.
65.8 M
LAST VALUE
-4.65%
2 YEAR CAGR
36.75%
5 YEAR CAGR
0.00%
10 YEAR CAGR